One of these applications was developed by delivering systemically injected exosomes to target epidermal growth factor receptors in breast cancer; the study stated that these exosomes successfully conveyed miRNA and anti-tumor agents into epidermal growth factor receptors [135]. This evidence concerns the gene EGFR and breast carcinoma.